Pathophysiology and Pharmacologic Treatment of Acute Spinal Cord Injury
Authors:
- Brian K. KwonBKBrian K. Kwon
- Jonathan N. GrauerJGJonathan N. Grauer
- Alexander R. VaccaroAVAlexander R. Vaccaro
- 1 January 2005
- book chapter
- Published by Elsevier
- p. 255-266
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injuryProceedings of the National Academy of Sciences, 2002
- Lipid peroxidation inhibition in spinal cord injuryNeuroReport, 2000
- Spinal cord injury-induced inflammation: A dual-edged sword2000
- Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow upJournal of Neurosurgery, 1998
- Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord InjuryJAMA, 1997
- Apoptosis and delayed degeneration after spinal cord injury in rats and monkeysNature Medicine, 1997
- Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2Journal of Neurosurgery, 1993
- Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up dataJournal of Neurosurgery, 1992
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryNew England Journal of Medicine, 1990
- Lipid Peroxidation‐Induced Inhibition of γ‐Aminobutyric Acid Uptake in Rat Brain Synaptosomes: Protection by GlucocorticoidsJournal of Neurochemistry, 1985